Digirad Corporation (NASDAQ:DRAD)

Digirad Corporation provides diagnostic solutions in the science of imaging primarily in the United States. The company operates in two segments, Digirad Imaging Solutions (DIS) and Diagnostic Imaging. The DIS segment offers imaging services programs for physicians who perform nuclear imaging, echocardiography, vascular ultrasound, or any combination of these procedures in their offices by leasing the imaging system, certified personnel, and other support required to perform imaging. This segment serves cardiologists, internal medicine physicians, and family practice doctors, as well as hospitals, multi-practice physician groups, and imaging centers. The Diagnostic Imaging segment manufactures and sells solid-state gamma cameras for nuclear cardiology and general nuclear medicine applications, as well as provides camera maintenance services to physician offices, hospitals, mobile service providers, and imaging centers. This segment’s products include Cardius 3 XPO and X-ACT rapid imaging dedicated cardiac cameras; ergo imaging system, a general purpose imager for hospital customers; and 2020tc family of gamma cameras. Digirad Corporation was founded in 1985 and is headquartered in Poway, California.